Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,002 public trials 2,553 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

NCT06833073

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +13 more
Locations
  • Michael G Oefelein Clinical Trials ( Site 0138) Bakersfield, California, United States
  • Genesis Research, LLC ( Site 0141) Los Alamitos, California, United States
  • USC Norris Comprehensive Cancer Center ( Site 0123) Los Angeles, California, United States
  • Genesis Healthcare-Torrance ( Site 0140) Torrance, California, United States
View all 89 locations
View Trial Details
Recruiting

Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental (InterCon) Countries

NCT07539844

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Instituto Alexander Fleming /ID# 281479 Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina
  • Fundacion Para La Investigacion Clinica Y Molecular Aplicada Del Cancer - Ficmac /ID# 282327 Bogotá, Bogota D.C., Colombia
  • Biomakers /ID# 280318 Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires /ID# 280315 Buenos Aires, Argentina
View Trial Details
Recruiting

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

NCT06511141

Conditions
Benign Prostatic Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +23 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Urology Associates Fairhope, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Tri Valley Urology Murrieta, California, United States
View all 23 locations
View Trial Details
Recruiting

The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

NCT06111781

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Washington Seattle, Washington, United States
View Trial Details
Recruiting

[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer

NCT00588185

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Consent only) Commack, New York, United States
View Trial Details
Recruiting

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

NCT03564340

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
Locations
  • University of Alabama_6th Ave Birmingham, Alabama, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber / Harvard Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
View all 53 locations
View Trial Details

Related conditions